Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03118375 · ClinicalTrials.gov registry record
Super Power in BAI
A clinical trial, sponsored by University of Miami.
- Terminated
- Registry status
- 8
- Enrollment target
NCT03118375: Clinical Trial study, sponsored by University of Miami.
NCT03118375 is a clinical trial that was terminated before completion, run by University of Miami. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03118375 was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the benefit of new super-power bone-anchored hearing aid (BAHA) processors in BAHA users. BAHAs are able to help people with mixed/conductive and single-sided hearing loss when they are unable to use or receive limited benefit from traditional hearing. Until recently, BAHAs were only recommended to people with up to a moderate hearing loss. New super-power BAHA processors may be able to help people who previously were not candidates for BAHAs or received limited benefit from them. The information collected in this study may lead to improved evaluation of and expanded treatment options for people considering BAHA. Different types of hearing tests will be used to compare the devices.
Primary Outcome
Conventional hearing test will be performed. Sound field testing will be performed to establish aided thresholds using the individual's current BAHA processor and super power BAHA processor
Interventions
- DEVICE super-power BAHA processor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2017-04-12 |
| Est. Completion | 2017-04-29 |
Why NCT03118375 stopped before completion
NCT03118375 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which super-power BAHA processor is the first listed.
NCT03118375 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03118375 about?
NCT03118375 is a clinical study titled "Super Power in BAI". The purpose of this study is to assess the benefit of new super-power bone-anchored hearing aid (BAHA) processors in BAHA users. BAHAs are able to help people with mixed/conductive and single-sided hearing loss when they are unable to use or receive limited benefit from traditional hearing. Until re...
What is the current status of trial NCT03118375?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2017-04-12. Estimated completion is 2017-04-29.
What interventions are being tested in trial NCT03118375?
The interventions under investigation include: super-power BAHA processor (DEVICE).
Who is sponsoring clinical trial NCT03118375?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI